{
    "title": "103_s1429",
    "content": "The Act titled \"Women and AIDS Research Initiative Amendments of 1993\" establishes a program for research on women and AIDS. This program is added to the Public Health Service Act. The Secretary shall establish a program for conducting biomedical and behavioral research on HIV cases in women, including prevention research. Research on the transmission of HIV to women will be provided for. The Secretary shall provide for research on the transmission of HIV to women, including prevention measures and clinical trials on preventing HIV infection by treating sexually transmitted diseases. Research is needed on preventing HIV transmission to women by treating sexually transmitted diseases. This includes measures to prevent exposure and transmission of the virus, such as prevention of facilitating STDs, rapid diagnostic tests, and single-dose therapy for treatable STDs. Research is needed on the development and dissemination of prevention programs to reduce substance abuse among women, as well as the progression of symptoms resulting from infection with a virus. The curr_chunk discusses prevention programs, research on symptoms of virus infection, treatment of infection cases, and behavioral research for prevention. The curr_chunk focuses on the treatment and prevention of virus infection, including clinical research and behavioral research. It also mentions gynecological evaluations for female subjects infected with the human immunodeficiency virus in clinical trials. The Secretary ensures that female subjects infected with HIV in clinical trials undergo gynecological examinations and receive follow-up services. The results of these examinations are analyzed to determine the relationship between HIV infection and gynecological health. The Secretary conducts or supports clinical trials to determine the effectiveness of standard treatments for gynecological conditions that arise as a result of HIV infection. The Secretary conducts clinical trials to determine the effectiveness of standard treatments for gynecological conditions resulting from HIV infection, including testing treatment protocols approved for men on women with HIV. Support services are also provided. The Secretary conducts or supports clinical trials to determine the effectiveness of treatment protocols approved for men on women with gynecological conditions resulting from HIV infection. Support services, including transportation, child care, medical and mental health services, treatment for drug abuse, and social services, are provided for women participating in these trials. The Secretary provides women participating in clinical trials with transportation, child care, and support services, including medical and mental health services, treatment for drug abuse, and services addressing domestic violence. These services are tailored to meet the specific needs of women in clinical trials. The Secretary provides services for women in clinical trials tailored to their specific needs, including training for trial conductors. Additionally, the Secretary conducts research on barrier methods for preventing sexual transmission of HIV. The Secretary conducts or supports research on barrier methods for preventing sexually transmitted diseases, including HIV, that women can use without their partner's knowledge. The Secretary prioritizes research needs identified at a National Institutes of Health meeting on topical microbicides, focusing on early infectious stages, formulation of new preparations, and clinical testing for safety and efficacy. The Secretary prioritizes research on topical microbicides, including preclinical evaluation, clinical testing for safety and efficacy, and epidemiological research on HIV risk factors for women. The Secretary conducts or supports epidemiological research to determine risk factors for HIV infection in women, including contraceptive methods, tampon use, relationship with other STDs, and substance abuse. The Secretary conducts research on risk factors for HIV infection in women, including contraceptive methods, tampon use, relationship with other STDs, substance abuse, and sexual activity. An interagency study is being carried out to monitor HIV progression in women and determine differences compared to men. The Secretary is conducting a study called the Women's Interagency HIV Study to monitor HIV progression in women compared to men. The study includes at least 5,000 women with HIV, will be conducted at multiple sites, and will last for a minimum of 8 years. The Secretary is conducting the Women's Interagency HIV Study with at least 5,000 women infected with HIV. The study will be conducted at multiple sites over a minimum of 8 years. It will focus on the relationship between CD4 cells and the development of serious illnesses in infected women. The study addresses the relationship between the number of cells in women with HIV infection and the development of serious illnesses. It includes gynecological conditions and other conditions specific to women not currently on the list of conditions maintained by the CDC. The term 'human immunodeficiency virus' refers to the agent for acquired immune deficiency syndrome. The term 'human immunodeficiency virus' refers to the agent for acquired immune deficiency syndrome. $20,000,000 is authorized for clinical trials in fiscal year 1994, with additional funding for 1995 and 1996. Authorized funding of $20,000,000 for clinical trials in fiscal year 1994, with additional funding for 1995 and 1996 as necessary for subsections (c)(2) and (c)(3). For fiscal year 1994, $10,000,000 is authorized for subsection (c)(3) and $15,000,000 for subsection (c)(4), with additional funding as needed for 1995 and 1996. For fiscal year 1994, $30,000,000 is authorized for prevention programs under subsection (d)(1), and $10,000,000 for subsection (d)(2), with additional funding as needed for 1995 and 1996. For fiscal year 1994, $10,000,000 is authorized for subsection (d)(2) and $15,000,000 for an interagency study under subsection (e), with additional funding as needed for 1995 and 1996."
}